Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Evangelia Zapanti"'
Autor:
George Simeakis, Maria Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki, Gregory Kaltsas, Evangelos Terpos
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 603 (2023)
High-dose intravenous steroid treatment (HDIST) represents the first choice of treatment for multiple sclerosis (MS) relapses. Chronic oral glucocorticoid (GC) administration correlates with bone loss whereas data regarding HDIST in MS are still conf
Externí odkaz:
https://doaj.org/article/89cd6cc51fb04fc8b525bc043f168d67
Autor:
Paraskevi Kazakou, Dimitrios Tzanetakos, Aigli G. Vakrakou, John S. Tzartos, Μaria-Eleptheria Evangelopoulos, Maria Anagnostouli, Panos Stathopoulos, Georgia N. Kassi, Leonidas Stefanis, Constantinos Kilidireas, Evangelia Zapanti
Publikováno v:
Clinical and Experimental Medicine.
Autoimmune thyroid disease (AITD) is the most common adverse effect in alemtuzumab (ALZ) treated relapsing–remitting (RR) multiple sclerosis (MS) patients. The objective of this prospective study was to analyze the occurrence, timing of onset, clin
Autor:
Paraskevi Kazakou, Marianna Theodora, Christina Kanaka-Gantenbein, Evangelia Zapanti, Helen Bouza, Chrysa Petropoulou, George Daskalakis, Stavroula A. Paschou, Eleni Anastasiou
Publikováno v:
Case Reports in Women's Health, Vol 20, Iss , Pp - (2018)
A 33-year-old Caucasian woman was referred at 24 + 3 weeks of gestation due to fetal tachycardia and hydrops. She had an uncomplicated pregnancy 16 years previously and was on levothyroxine after total thyroidectomy for Graves' disease 6 years previo
Externí odkaz:
https://doaj.org/article/dad1d4cac24a41a6a41eb848f71b3e17
Autor:
Maria Anagnostouli, Kostas Athanasiou, Evangelos Terpos, Nikolaos Fakas, John Koutsikos, Maria Alevizaki, George Simeakis, Evangelia Zapanti, Athanasios Papatheodorou, Katerina Saltiki, George Papatheodorou
Publikováno v:
Endocrine Abstracts.
Autor:
Evangelia Zapanti, George Mastorakos, N Salakos, Panagiota Papargyri, Alexandra Bargiota, Loukas Papargyris
Publikováno v:
Expert Review of Endocrinology & Metabolism. 13:317-332
Introduction In the human organism, a constant interplay exists between the stress system [which includes the activity of the hypothalamic-pituitary-adrenal (HPA) axis] and the adipose tissue. This interplay is mediated by hormones of the HPA axis su
Autor:
George Mastorakos, Ioannis A. Sfontouris, Evangelia Zapanti, Maria Gazouli, Charalambos Siristatidis, D. Kalogiannis, S. Spanou
Publikováno v:
Journal of Assisted Reproduction and Genetics. 35:1019-1025
PURPOSE: To calculate the concentrations of interleukin 15 (IL-15) in follicular fluid (FF) and evaluate their relation with oocyte maturation, follicle size, and patients’ body mass index (BMI) and age. METHODS: Follicular fluid specimens were obt
Autor:
M. E. Evangelopoulos, Elissavet Andreadou, Dimitrios Tzanetakos, John Tzartos, Leonidas Stefanis, Georgios Koutsis, Elias Gialafos, Paraskevi Kazakou, Aigli G Vakrakou, A. Dimitrakopoulos, Nikolitsa Kafasi, Panos-Alexis Stathopoulos, Evanthia Zampeli, Dimitra Rontogianni, Eleni Lekka, George E Fragoulis, Constantinos Kilidireas, Evangelia Zapanti, Stamatios Theocharis, Maria Anagnostouli
Publikováno v:
Journal of Neuroimmunology. 361:577759
We aimed to determine whether Alemtuzumab-induced immune reconstitution affects immunoglobulin and complement levels in the serum of Relapsing-Remitting Multiple Sclerosis (RRMS) patients. IgG4-levels were increased 24-months after treatment initiati
Publikováno v:
Endocrine Abstracts.
Autor:
Paraskevi Kazakou, Elisabeth Andreadou, Evangelia Zapanti, Constantinos Kilidireas, Aigli G Vakrakou, Georgios Koutsis, Dimitrios Tzanetakos, John Tzartos, Maria Anagnostouli, Maria Eleptheria Evangelopoulos
Publikováno v:
Journal of the Endocrine Society
Alemtuzumab, a humanized anti-CD52 monoclonal antibody, is approved for the treatment of highly active relapsing-remitting multiple sclerosis (MS). The principal adverse effect is the development of secondary autoimmune disorders during the immune re
Autor:
Efthimios Karakostas, Georgios Charitoudis, Theodore Karatzas, Ioannis Vasileiadis, Evangelia Zapanti, Georgios Boutzios
Publikováno v:
The American Journal of Surgery. 212:946-952
Backround We investigated the efficacy of thyroglobulin antibodies (TgAb) in detecting malignancy in indeterminate thyroid nodules and evaluated the possible association between TgAb and autoimmunity in papillary thyroid carcinoma (PTC). Methods This